Race Oncology |
High $1.29 |
Low $1.18 |
Trades 155 |
Turnover $303,224 |
Volume 249,053 |
| 30 June 2023 at 4:10pm | ||||
|
Market Cap (14-Nov) $307,828,256 (417th) |
Close (30-Jun) $1.23 |
Volume (30-Jun) 249,053 |
Shortsold (9-Nov) 19,354 (0.01%) (577th) |
|
52w High $3.79 |
52w Low $1.40 |
P/E - |
EPS -0.06 |
Race Receives Governance Approval for AML EMD & MDS Trial
RAC released this announcement to the ASX on 12 May 2022, 9:21. The announcement is marked as price sensitive, and is 4 page(s) in length and 158.97kb in size.
You can view all announcements from RAC and see how they appear on a price chart on the announcements page.
At the date of this announcement, RAC was 0.010% short sold according to ASIC data. It was ranked the 645th most shorted stock on the ASX. It is now ranked as the 577th most shorted stock on the ASX with 0.010% of total shares short sold as of the latest reported data (09 November 2026).
| Other Recent Announcements from RAC | |
|---|---|
| Notification of cessation of securities - RAC | 29 June 2023, 9:54 |
| Proposed issue of securities - RAC | 29 June 2023, 9:52 |
| Initial Director's Interest Notice | 29 June 2023, 9:46 |
| Race Receives Governance Approval for AML EMD & MDS Trial | 12 May 2022, 9:21 |
| Quarterly Activity Report & Appendix 4C | 21 April 2022, 9:11 |
| CEO & CSO Employment Update | 12 April 2022, 13:22 |
| Becoming a substantial holder | 8 April 2022, 17:28 |
If you were already registered, log in here.